Bayer

​​​Bayer is a global enterprise with core competencies in the life science fields of healthcare and nutrition. Its products and services are designed to help people and the planet thrive by supporting efforts to master the major challenges presented by a growing and aging global population. Bayer is committed to driving sustainable development and generating a positive impact with its businesses. At the same time, the Group aims to increase its earning power and create value through innovation and growth. The Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2020, the Group employed more than 99,000 people and had sales of EUR 41.4 billion. R&D expenses before special items amounted to EUR 4.9 billion.​

Bayer is an international life sciences company that has been operating in Turkey for nearly 70 years. The company supplies important healthcare and agricultural products to Turkey. In the last few years, various innovative products that meet the medical and agricultural needs of Turkey have been put on the market by Bayer. Bayer Pharmaceuticals is among the top 5 in the Turkish pharmaceutical market. In addition to being an important player in women's health, cardiology, ophthalmology, hematology, oncology and pulmonology, Bayer also has a strong position in the field of radiology. The Consumer Health Division ranks second in the OTC market in Turkey and is the market leader in various key segments. The Crop Science Division offers innovative solutions that create value for the agricultural sector and farmers in Turkey. The Crop Science Division in Turkey is active in vegetable seeds, bioscience and environmental science.

Bayer Turkey, which is among the top 20 countries in the world of Bayer, has 1,011 employees as of today and generated sales of EUR 373.8 million for 2020 in Turkey. With its young and well-educated population, Turkey is an attractive and long-term resource for global talent. Since Bayer's establishment in Turkey, over 7,000 people have worked for the company in Turkey.

Bayer's activities in Turkey are not limited to sales and marketing as Turkey is an important regional production and development base for Bayer. There are two production facilities for the Crop Science products in Turkey, one in Gebze, Kocaeli and the other in Mustafa Kemal Paşa, Bursa. In addition, Bayer has an R&D Center in Antalya.

Bayer Turkey has a partnership for the production of Bayer products in Sanofi's production facility in Lüleburgaz, Kırklareli. Within the scope of this partnership, a big step was taken in order to realize the production of an important drug in the cardiology product portfolio in Turkey in 2020. Bayer plans to make an investment of over EUR 4.5 million. It triples the value-based production volume of the Pharmaceutical Division. With this localization project, the largest such effort in terms of value among cardiology products in Turkey, Bayer raises the localization percentage of products in the current cardiovascular market to 40 percent.

Guided by its purpose of "Science for a Better Life", Bayer carries out many corporate social responsibility (CSR) projects in Turkey. Bayer Turkey has brought together more than 41,000 children with science in 10 years with the Bayer Young Science Ambassadors project, realized in cooperation with the Community Volunteers Foundation (TOG).

Bayer has evaluated the projects of more than 5,000 students in the Bayer Science Competition for high schools, organized for the seventh time this year, which attracted participation from schools all over Turkey. In addition to its CSR projects, Bayer has undertaken to support the entrepreneurship ecosystem and has been continuing the G4A Turkey 2021 project for four years. Within the scope of the project, Bayer contributed TRY 2.5 million to the entrepreneurship ecosystem in the past three years.